Updated management of hepatocellular carcinoma

Hepatology

Volumn 54, Issue 3, 2011, Pages 1113-

  Lo, Gin Ho ^a  

^a E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; SORAFENIB;

ADVANCED CANCER; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL PRACTICE; HUMAN; LETTER; LIVER CELL CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL TIME; TRANSARTERIAL CHEMOEMBOLIZATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS;

EID: 80052024274     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24378     Document Type: Letter

References (6)

1. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
2. Luo BM, Wen YL, Yang HY, Zhi H, Xiao XY, Ou B, et al. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma. World J Gastroenterol 2005; 11: 6277-6280.
3. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001; 92: 1516-1524.
4. Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Dux M, Kauffmann GW. Long-term results of interventional treatment of large unresectable hepatocellular carcinoma: significant survival benefit from combined transcatheter arterial chemoembolization and percutaneous ethanol injection compared to TACE monotherapy. Rofo 2004; 176: 1794-1802.
5. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
6. Lin CP, Yu HC, Cheng JS, Lai KH, Lo GH, Hsu PI, et al. Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma. J Chin Med Assoc 2004; 67: 602-610.